HJB - Your Trusted Biologics CDMO Partner
HJB, CDMO, biologics, HJB Bio, hjbbio, China CDMO, 杭州奕安济世, Just Bio, Just biotherapeutics, HJB bio, HJB China, Hangzhou HJB
Background:
This case involves implementing an accelerated clone stability study to shorten the CLD timeline.
Result:
Initiated an accelerated clone stability study to support earlier final top clone selection. All clones tested showed highly similar stability results compared to conventional stability study. Thus, the accelerated study allows for earlier stability prediction and final clone selection, shortening the CLD timeline by 2 months and the IND filing timeline accordingly.
CDMO@hjbbio.com
